Expert consensus on rational use of immunomodulators for common respiratory diseases in children(2024 edition)
Clinical Pharmacology Group,Pediatrics Branch of Chinese Medical Association
The National Clinical Medical Research Center for Child Health and Disease
Collaborative Group of Rational Drug Use,Respiratory Group,Pediatrics Branch of Chinese Medical Association
Zhongguo Yishi Xiehui Erke Yishi Fenhui Ertong Huxi Zhuanye Weiyuanhui
Zhongguo Fuyou Baojian Xiehui Ertong Biantai Fanying Zhuanye Weiyuanhui Huxixuezu
《Zhongguo Shiyong Erke Zazhi》Bianji Weiyuanhui
DENG Yu
FU Zhou
LI Qiu
LIU En-mei
LUO Zheng-xiu
TANG Xue-mei
TIAN Dai-yin
SUN Jin-qiao
ZHANG Xiao-bo
CHEN Yao-long
TIAN Man
ZHAO De-yu
ZHAO Wei
HONG Jian-guo
DONG Xiao-yan
LU Quan
Abstract：More and more attention has been paid to the role of immunomodulators in the prevention and treatment of respiratory diseases in children.There are a wide variety of immunomodulators with various mechanisms,their clinical efficacy needs to be further verified,and high-quality research evidence needs to be substantiated.In order to further standardize the rational use of immunomodulators,the Clinical Pharmacology Group of the Pediatrics Branch of the Chinese Medical Association,together with the editorial board of the Chinese Journal of Practical Pediatrics,has invited clinical experts in children's respiratory,immune,infection,allergy,otolaryngology and other disciplines to formulate The Expert Consensus on the Rational Use of Immunomodulators for Common Respiratory Diseases in Children based on clinical practice and evidence-based medicine to systematically summarize the mechanism of commonly used immunomodulators and the clinical evidence,usage and dosage etc.in common childhood respiratory diseases.Six consensus opinions have been put forward concerning their application in common respiratory diseases such as childhood asthma,recurrent respiratory infection,pneumonia,chronic sinusitis and allergic rhinitis,aiming at guiding pediatricians to use immunomodulators scientifically and reasonably.
Keywords：immunomodulatorsrespiratory diseasesexpert consensuschild
Publication Date：2024-11-06
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：9( 801-809 )